ITMCTR2000003867尚未招募1 期
A Multi-Centered Randomized Double-Blinded Parallel Controlled Clinical Study on Efficacy of Warming the Kidney, Invigorating the Spleen, Activating Blood and Removing Edema Method in the Treatment of Chronic Heart Failure
Yueyang Hospital of Integrated Traditional Chinese and Western Medicine,Shanghai University of Traditional Chinese Medicine0 个研究点开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional study
入排标准
- 年龄范围
- 18 至 74（—）
- 性别
- All
入选标准
- •1. Aged between 18 to 74years;
- •2. Those who meet the diagnostic criteria of Western medicine;and with II to III degree of the cardiac function stardand of New York Heart Association;
- •3. Those whose BNP content >= 150pg/ml(or Pro-BNP >= 600pg/ml);
- •4. Those whose the left ventricular ejection fraction (LVEF) was <= 40%;
- •5. Those who meet the syndrome differentiation of TCM;
- •6. Those who participate in this clinical trial voluntarily, understand and sign the informed consent.
排除标准
- •1. Combine the serious primary disorders;
- •2. Combine serious infection;
- •3. Plan to accept Cardiac surgical procedures;
- •4. Critical patients who may cannot survive to the end of the trial;
- •5. Pregnant or lactating women;
- •6. Allergic Constitution, allergic to many kinds of medicine;
- •7. Patients with mental disorder and unwilling to cooperate;
- •8. Other conditions that are not suitable for participation in clinical trials.
研究者
相似试验
已完成
2 期
Effect of Mupirocin ointment in bacterial skin infectionsCTRI/2022/02/040436Apex Laboratories Pvt Ltd200
招募中
不适用
Study to see the effect of Shred N Fit in obesity.CTRI/2023/02/050109Gangwal Healthcare Pvt Ltd
已完成
3 期
A multicentric randomized comparative phase III clinical study of FDC of Azelnidipine 16 mg plus Telmisartan 40 mg Film Coated Tablets Versus FDC of Amlodipine 5 mg plus Telmisartan 40 mg tablets in subjects with stage 2 hypertensioCTRI/2022/07/044031Mascot Health Series PVT Ltd220
已完成
4 期
linastatin in patient with Trauma to prevent progression to multiple organ dysfunctioCTRI/2012/11/003144Bharat Serums and Vaccines Ltd
已完成
不适用
To evaluate how safe and effective Salacia is in Obese or Overweight subjectsCTRI/2018/03/012414OmniActive Health Technologies Ltd28